UBS and Warburg Research analysts forecast a bleak recovery ...
UBS and Warburg Research analysts forecast a bleak recovery for BASF due to low demand and high costs, likely to hit EBIT guidance's lower end. Citi analyst sees stagnating end markets further impacting earnings.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000001559ac498760b5.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment